Áttétes emlőrák: vizsgálatok itt: Szaúd-Arábia
4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleS1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
- Where
- Riyadh
- Életkor
- 18 év and over
- People
- 491 worldwide
- Run by
- SWOG Cancer Research Network
See details and how to joinNCT03418961 - No phaseTaking peopleBEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy
- Where
- Jeddah, Mecca, Riyadh
- Életkor
- 18 év and over
- People
- 109 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07597993 - 2. fázisTaking peoplePrediction of Treatment Efficacy of the Combination of Palbociclib/(Letrozole or Anastrozole) in First Line Metastatic Women With Luminal, HER2 Negative Advanced Breast Cancer, Using Infrared Laser Spectroscopy Analysis on Liquid Biopsies.
- Where
- Riyadh
- Életkor
- 18 év and over
- People
- 80 worldwide
- Run by
- International Cancer Research Group, United Arab Emirates
See details and how to joinNCT05190094 - No phaseNot yet taking people in Szaúd-ArábiaPalbociclib Induced Neutropenia; Risk Factors and Treatment Outcome in Metastatic Breast Cancer Patients
- Where
- Al Madīnah
- People
- 54
- Run by
- Assiut University
See details and how to joinNCT06076772